Skip to main content
KickboxHub
Back to News
Enfusion 165 and 166: November 14 fight-card preview

Enfusion 165 and 166: November 14 fight-card preview

October 31, 20262 min read

Enfusion has announced Enfusion 165 and 166 for November 14, 2026 in Groningen, the Netherlands. Luciano Bitto faces Dylan Westerhuis on the 165 card; Sakvan Arab meets Miguel Paays on the 166 card.

Enfusion 165: featured matchups

Announced billingMatchup
Main event — heavyweightLuciano Bitto vs Dylan Westerhuis
Co-main — super welterweightBoris Alexander Perez Meija vs Adam Bekhit

Enfusion 166: featured matchups

Announced billingMatchup
Main event — bantamweightSakvan Arab vs Miguel Paays
Co-main — middleweightOmid Nosrati vs Piet van den Berg

This is a featured-bout selection, not the full card. See the official event page for the remaining announced pairings. Cards can change.

Venue, schedule and viewing

The organizer's linked ticket listing identifies Martiniplaza in Groningen and displays November 14, despite the older date in its URL. It advertises doors at 13:00 and a programme start at 14:00. Enfusion's card labels separately show 19:00 for 165 and 21:15 for 166.

Those are advertised listings, not a verified broadcast timetable. Check the organizer before travelling; timezone conversions and event-specific viewing access remain unconfirmed. A generic on-demand link does not establish a live stream.

Results and updates

No results are available before the event. This page will retain separate sections for the two shows when verified outcomes become available. Withdrawals and cancellations will be distinguished from completed bouts, and unconfirmed results will remain explicit.

The linked fighter pages show KickboxHub's documented histories; they are not claims of complete career coverage. Read how records are interpreted and follow the Enfusion event archive for related coverage.

Mentioned Fighters

Related Organizations

Lukas Krylovas

Written by

Lukas Krylovas

CEO of Kickboxhub

Comments (0)

Sign in to leave a comment.

No comments yet. Be the first!